Key facts
- This page summarizes Daniel E. Handley's Form 4 filing for Predictive Oncology Inc. (POAI).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 05 Oct 2022, 12:42.
Daniel E. Handley - 03 Oct 2022 Form 4 Insider Report for Predictive Oncology Inc. (POAI)
- Reporting relationship
- Director
- Issuer ticker
- POAI
- Reported as of
- 03 Oct 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 05 Oct 2022, 12:42:51 UTC
- Prior SEC filing
- 05 Jul 2022
- Next SEC filing
- 30 Nov 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Bob Myers, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Daniel E. Handley filed Form 4 for Predictive Oncology Inc. (POAI) on 05 Oct 2022.
Change
- Previous filing in this sequence was filed on 05 Jul 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
POAI
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +23,147
- Change %
- +28%
- Price
- $0.000000
- Shares after
- 104,513
- Date
- 03 Oct 2022
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
SEC remarks
Exhibit 24.1 Power of Attorney filed herewith.